SPLPETRO2025-07-012025-09-30SPLPETRO2025-09-30SPLPETRO2025-03-31SPLPETRO2025-04-012025-09-30SPLPETRO2025-07-012025-09-30in-capmkt:OtherExpenses1MemberSPLPETRO2025-04-012025-09-30in-capmkt:OtherExpenses1MemberSPLPETRO2025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1SPLPETRO2025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500405SPLPETRONOTLISTEDINE0663A1033SUPREME PETROCHEM LIMITEDMain BoardEquity2025-04-012026-03-312025-10-242025-10-16INRLakhsQuarterlySecond quarterSingle segmentThe Group operates in Styrenics and Allied Products which in the context of Ind AS-108 Operating Segments constitutes a single reportable business segment.2025-10-2415:30:002025-10-2417:25:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated11177567000871900001126475700075830390002194620000-31340300017083700029922000186328000755262000106066050006581520000658152000965400007687900017341900004847330000000484733000405500048878800048290200018310004060000-500037608300022.572.57002.572.571 The Board of Directors in their meeting held on October 24, 2025 have declared an Interim Dividend of Rs.2.50 per share of the Company (Face Value Rs.2/- per share). <BR> 2 During the quarter, the Company commissioned its first Line of ABS project with 70,000 TPA capacity at Amdoshi, Dist Raigad, Maharashtra, under license from M/s Versallis S.P.A., Italy and commenced production from September 25, 2025. Expanded ABS Compounding facility also commenced production from September 25, 2025. <BR> 3 The above Statement of Unaudited Standalone and Consolidated Financial Results (" Unaudited Financial Results") comprising of the financial results of the parent company and its subsidiary Xmold Polymers Pvt. Ltd. ("Xmold") (together known as Group) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" (Ind AS - 34) as prescribed under Section 133 of the Companies Act, 2013 ("The Act") read with the relevant rules thereunder. <BR> 4 These Unaudited Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on October 24, 2025. The Statutory Auditors of the Company have carried out a Limited Review of the said Financial Results. These Financial Results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, as amended. <BR> 5 The Company acquired control on Xmold with effect from April 1, 2025, consequently, there are no corresponding figures for the consolidated financial results for the quarter ended September 30, 2024 and the previous year ended March 31, 2025. <BR> 6 The Group operates in 'Styrenics and Allied Products' which in the context of Ind AS-108 "Operating Segments" and in the opinion of the Chief Operating Decision Maker constitutes a single reportable business segment. <BR> 7 Finance cost significantly comprises of interest expense on lease pertaining to Ind AS 116-Leases. The Company continues to remain debt free. <BR> 8 The Company does not have any associates or joint ventures. <BR> <BR> 2025-04-012025-09-30UnauditedConsolidated2519664700023955200025436199000172818220004651300000-5268980003535250006152900037009800014856000002367697600017592230000175922300036706800086917000453985000013052380000000130523800050280001310266000130115100040870005038000-1000037608300026.926.92006.926.92OTHER EXPENSES755262000OTHER EXPENSES148560000014984524000416830000015011400016919000000536040001690300012352800019403500004300500015805427000835268100019748400002833513000975925000244594200076750009505400083329490003649400046530200017187426000003299285300037608300021832678000222087610004509000022253851000113560700000037957000117356400064127000490553000001728244000323744000115600007598658000761021800074045000086744120002855290004625800045590000901075800000107390020003299285300061529000-132185100012534560000-2504910001647000514000-67100018304000-18230550000105163000036942600056000038810006035000-45458000-384300010356800000000-1187450007073000-19910000-16349490001242740000005642230000-4399490000003205610000000146800012690870000001015000000000000000000131998000088000-14662440000000000001324100011174700014103100006152900000-1596827000-35030200000-350302000087220850005219065000Remeasurement of the defined benefit plans54160005416000Remeasurement of the defined benefit plans671600067160001361000168800040550005028000